Physician profile
Todd Chertow
NPI 1922046523
$9,560.81
in general payments reported to CMS, 2019-2025
13 companies · $2,505 in 2025
The $2,505 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,854 · 2020: $15.09 · 2021: $24.41 · 2022: $1,076 · 2023: $925 · 2024: $2,162 · 2025: $2,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,123 · Food and Beverage: $1,392 · Consulting Fee: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,122.91 |
| Food and Beverage | $1,391.62 |
| Consulting Fee | $1,077.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,342.65 | 2019-2025 | Mako, Triathlon, Tornier Perform Reversed Glenoid |
| Moximed, INC | $2,065.61 | 2025 | Misha Knee System, Small, Left |
| Liberty Surgical INC. | $1,035.00 | 2019 | |
| Arthrosurface Incorporated | $1,003.67 | 2019 | |
| Pacira Therapeutics, INC. | $637.09 | 2019 | |
| Smith+Nephew, INC. | $206.05 | 2020-2025 | Real Intelligence |
| Vertex Pharmaceuticals Incorporated | $67.31 | 2025 | |
| Zimmer Biomet Holdings, INC. | $62.37 | 2025 | Persona |
| Trice Medical, INC. | $57.15 | 2019 | |
| Linvatec Corporation | $37.36 | 2019 | |
| Paladin Technology Solutions | $16.90 | 2025 | |
| Fx Shoulder Solutions, INC | $16.36 | 2019 | |
| Glaxosmithkline, LLC. | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Chertow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.